bulk drugs
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......
Healthcare
Exclusive: Sole bidder emerges for bankrupt pharma firm Parabolic Drugs
Parabolic Drugs Ltd, a listed bulk drugs manufacturer which is currently undergoing insolvency proceedings, has received a takeover offer from ......
Healthcare
ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drugmaker, two ......
Healthcare
Mid-market PE consortium in talks to buy Actis' stake in Symbiotec
Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......
Healthcare
OrbiMed invests $42.5 mn in Vivimed's bulk-drugs unit
Healthcare-focussed investment firm OrbiMed, which closed its third Asia private equity fund this month, is investing $42.5 million (Rs 276.7 ......
Healthcare
Symbiotec Pharmalab gets interest from new set of PE firms
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......
Healthcare
Strides Shasun to acquire Perrigo API India for $14.8 mn
Drugmaker Strides Shasun Ltd said on Friday it has agreed to acquire Perrigo API India Pvt Ltd for Rs 100 ......
Healthcare
Strides Shasun to hive off bulk drugs business
Drugmaker Strides Shasun Ltd said on Wednesday it has received board approval to hive off its active pharmaceuticals ingredients (API) ......